Chapter 2 (E1) Flashcards

Cost and timeline of drug development/discovery, naming drugs.

1
Q

A compound that affects physiological functioning once absorbed into the body.

A

What is a drug?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The cooperative effort of various disciplines to bring a drug from concept to market.

A

What is drug discovery?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List 3 key individuals involved in the drug discovery process.

A

1) Molecular biologists
2) Medicinal chemists
3) Lawyers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

A general rule of thumb in the drug discovery process is that the profit of { } successful drug(s) must be able to support approximately { } drug(s) in development.

A

Blank #1) 1
Blank #2) 8.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the main 3 considerations when choosing a profitable disease area?

A

Choose diseases that are:

1) Highly profitable b/c they affect a lot of people

2) Without current or effective treatment

3) Requiring long-term treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are 2 other strategies to consider when choosing a profitable drug project?

A

1) “Me too” drugs
2) Finding a new mode of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the purpose of developing “me too” drugs?

A

To push a similar drug onto the market just b/c there’s enough need and enough patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does finding a new mode of action for a drug entail?

A

Finding a new receptor/enzyme/target

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Site of action for a drug that controls a biological response.

A

What is a target?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are 3 general examples of drug targets?

A

Receptors, enzymes, & nucleic acids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Term used describe a promising target.

A

What is druggable?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do you determine the structure of a drug target?

A

X-Ray crystal structure data if available

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the difference between the “one drug, one target” and “multi-target” approaches to identifying a target?

A

“One drug, one target” is the traditional approach that can prevent or greatly reduce side effects since the drug only hits one target.

“Multi-target” is the newer approach that hits several targets weakly, and the combined weak responses across multiple pathways could yield a larger biological effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the major pro/up-side to the “multi-target” approach to target selection?

A

You can hit multiple pathways with a single drug, effectively reducing the amount of medicine required, especially for complex diseases where the pathogenesis depends on a series of simultaneous biochemical events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Method to measure the activity of a compound.

A

What is an assay?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the 3 main types of assays (ordered from least expensive to most expensive)?

A

1) Biochemical
2) Cellular
3) Animal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

The study of { } in biochemical assays is essential to determining how a drug binds to a specific receptor or checking the rate of an enzyme-catalyzed reaction.

A

Pharmacodynamics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Method of quickly testing a library of hundreds to thousands of compounds for activity against a target via a robot.

A

What is high-throughput screening (HTS)?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How does high-throughput screening (HTS) of enzymes typically occur in biochemical assays (HINT: Pharmacokinetics)?

A

Biologists typically follow the reaction profile of the enzyme with and without the drug present via UV-Vis and a plate reader

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How does high-throughput screening (HTS) of receptors typically occur in biochemical assays (HINT: there are 2 main methods discussed in lecture)?

A

1) Tagging drug w/ radioactive isotope

2) Fluorescence assay or UV-Vis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How are compounds chosen for biochemical assays?

A

A class of molecules is usually known for a target depending on available literature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How many tests are run during a biochemical assay?

A

As many as needed for all unique compounds, at varying concentrations, duplicated or triplicated

23
Q

Where or how do we get the compounds needed for biochemical assays (HINT: 3 solutions all involving money)?

A

1) Synthesize them
2) Merge/buy a company already studying compound of interest
3) Renting out a company

24
Q

What is the general purpose of cellular assays during assay development?

A

To see how a compound behaves throughout a whole cell

25
Q

What is the greatest achievement of a cellular assay that graduates a hit into a lead?

A

Being able to cross the cell membrane

26
Q

What model system is used to determine if a drug can pass through the cell membrane? How does this model function?

A

Caco-2 cells - replicate permeability of intestinal lining

27
Q

Name 2 other criteria that graduate a hit to a lead.

A

1) Cytotoxicity
2) Metabolic profile

28
Q

What is the goal of lead discovery?

A

To find compounds that show modest activity in biological screenings

29
Q

What is a possible setback to using genetically engineered cells for cellular assays?

A

Random mutations

30
Q

What is the solution to the random mutations within genetically engineered cells found during cellular assays?

A

Establishing a control compound that works in a non-mutated cell

31
Q

What is the general purpose of animal assays during assay development?

A

To begin understanding pharmacokinetics

32
Q

Biochemical & cellular assays are considered in { } while animal assays are considered in { }.

NOTE: these are Latin phrases

A

1) Vitro
2) Vivo

33
Q

This set of studies in lead optimization looks at how structure impacts function.

A

What are structure-activity relationship (SAR) studies?

34
Q

A compound that is optimized to show desirable properties.

A

What is a candidate?

35
Q

A promising candidate is also known as an NCE or an API. What do these acronyms stand for?

A

NCE - new chemical entity

API - active pharmaceutical ingredient

36
Q

What is the purpose of a patent in the pharmaceutical industry, and when is it usually filed?

A

A legal document that prevents other pharma companies from using compounds described in the patent; patents are filed early into lead optimization

37
Q

What 4 criteria do preclinical trials assess?

A

1) Drug safety
2) Side effects
3) Dosing
4) Toxicity

38
Q

What document has to be filed following preclinical trials?

A

Investigational new drug (IND)

39
Q

What is the goal of Phase I of clinical trials? There are 3 criteria studied.

A

Determining dosage, tolerance, and safety

40
Q

What is the goal of Phase II of clinical trials? There are 4 criteria studied.

A

Measuring efficacy, dosing, side effects, and safety

41
Q

What is the goal of Phase III of clinical trials? There 2 criteria studied.

A

1) Efficacy over a wider range of demographics

2) Long-term safety

42
Q

What is the goal of Phase IV or launch? There are 2 criteria studied.

A

1) Continued efficacy
2) Long-term safety

43
Q

In this type of clinical trial study, patients don’t know if the drugs they receive are real or placebos.

A

What is single-blind?

44
Q

In this type of clinical trial study, patients NOR doctors know if the drugs administered are real or placebos.

A

What is double-blind?

45
Q

What is required to re-brand a drug that is already on the market?

46
Q

Why would the fast-tracked/accelerated review of an IND be required?

A

For diseases that are life-threatening or are in need for immediate treatment

47
Q

If an IND needs a fast-tracked review, then Phase { } will need to be lengthened.

48
Q

What type of NDA is required for generic drugs, and when is it filed?

A

Abbreviated - filed after OG drug patent expires

49
Q

True or false: Generic drugs are required to have the same API concentration in the body, same dose, quality/purity, intended use, and way of administering as brand-name drugs.

50
Q

Why are generic drugs cheaper than name-brand drugs?

A

They don’t require all the pre-clinical and clinical trials

51
Q

What is the purpose of a mass balance study, and what is required for it?

A

Mass balance studies require a radiolabelled drug administered to a site where it won’t be metabolized to check if the drug properly eliminated in the urine or feces

52
Q

What is the percent threshold for a valid mass balance study (i.e., how much of the drug must be recovered from waste)?

53
Q

List the 4 methods of naming pharmaceutical drugs along with relevant associated characteristics of these naming conventions.

A

1) Chemical identifier - notebook #
2) Chemical name - IUPAC
3) Generic name - contains API, assigned by USAN, approved by WHO
4) Brand name - catchy, determined by linguist, approved by FDA